ArticleJournal of clinical microbiology2006
Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum.
Article in Journal of clinical microbiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Sputum signatures for invasive pulmonary aspergillosis in patients with underlying respiratory diseases (SPARED): study protocol for a prospective diagnostic trial.BMC infectious diseases · 2018Trial
- Trial
- A Cross-Domain Framework for the Dual Nature of Geotrichum and Magnusiomyces Across Plant, Food, and Clinical Systems.Current microbiology · 2026Review
- Biomarkers in Invasive Pulmonary Fungal Infections: Where Do We Stand?Journal of fungi (Basel, Switzerland) · 2026Review
- Disseminated fungal infection withOxford medical case reports · 2025Article
- Geotrichosis: fungemia in a patient with acute lymphoblastic leukemiaBiomedica : revista del Instituto Nacional de Salud · 2023Article
- β-1,3-d-Glucan and Galactomannan as Biomarkers for the Detection of InvasiveJournal of clinical microbiology · 2022Article
- A case ofAccess microbiology · 2022Article
- Genome sequence of the opportunistic human pathogen Magnusiomyces capitatus.Current genetics · 2019Article
- Cutaneous geotrichosis due toAccess microbiology · 2019Article
- Rare fungal infectious agents: a lurking enemy.F1000Research · 2017Review
- Geotrichum capitatum septicemia: case report and review of the literature.Mycopathologia · 2015Review
- Invasive fungal infection caused by geotrichum capitatum in patients with acute lymphoblastic leukemia: a case study and literature review.International journal of clinical and experimental medicine · 2015Article
- Misidentification of Saprochaete clavata as Magnusiomyces capitatus in clinical isolates: utility of internal transcribed spacer sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry and importance of reliable databases.Journal of clinical microbiology · 2014Article
- Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing.PloS one · 2014Article
- Galactomannan testing for early diagnosis of Exserohilum rostratum infection.Journal of clinical microbiology · 2013Article
- Galactomannan enzymatic immunoassay cross-reactivity caused by Prototheca species.Journal of clinical microbiology · 2012Article
- Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay.Journal of clinical microbiology · 2012Article
- Cross-reactivity of Aspergillus galactomannan in an HIV-infected patient with histoplasmosis.Medical mycology case reports · 2012Article
- Chitin, chitinase responses, and invasive fungal infections.International journal of microbiology · 2012Article
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report three cases of invasive Geotrichum capitatum infection in patients with acute leukemia for which an enzyme-linked immunosorbent assay (ELISA) for Aspergillus galactomannan was positive, with no evidence of aspergillosis. Supernatants obtained from suspensions of 17 G. capitatum strains gave positive reactions with the Aspergillus galactomannan ELISA. These clinical and laboratory data seem to suggest that G. capitatum produces a soluble antigen that is cross-reactive with Aspergillus galactomannan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.